EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?
AbstractEnhancer of zeste homolog 2 (EZH2), a histone methyltransferase, catalyzes tri-methylation of histone H3 at Lys 27 (H3K27me3) to regulate gene expression through epigenetic machinery. EZH2 functions as a double-facet molecule in regulation of gene expression via repression or activation mechanisms, depending on the different cellular contexts. EZH2 interacts with both histone and non-histone proteins to modulate diverse physiological functions including cancer progression and malignancy. In this review article, we focused on the updated information regarding microRNAs (miRNAs) and long non coding RNAs (lncRNAs) in regulation of EZH2, the oncogenic and tumor suppressive roles of EZH2 in cancer progression and malignancy, as well as current pre-clinical and clinical trials of EZH2 inhibitors. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Yan, K.-S.; Lin, C.-Y.; Liao, T.-W.; Peng, C.-M.; Lee, S.-C.; Liu, Y.-J.; Chan, W.P.; Chou, R.-H. EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe? Int. J. Mol. Sci. 2017, 18, 1172.
Yan K-S, Lin C-Y, Liao T-W, Peng C-M, Lee S-C, Liu Y-J, Chan WP, Chou R-H. EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe? International Journal of Molecular Sciences. 2017; 18(6):1172.Chicago/Turabian Style
Yan, Ke-Sin; Lin, Chia-Yuan; Liao, Tan-Wei; Peng, Cheng-Ming; Lee, Shou-Chun; Liu, Yi-Jui; Chan, Wing P.; Chou, Ruey-Hwang. 2017. "EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?" Int. J. Mol. Sci. 18, no. 6: 1172.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.